Gewählte Publikation:
SHR
Neuro
Krebs
Kardio
Lipid
Stoffw
Microb
Verheyen, N; Rainer, P.
Rarely cardiomyopathies
J KARDIOL. 2023; 30(5-6): 124-129.
Web of Science
- Führende Autor*innen der Med Uni Graz
-
Verheyen Nicolas Dominik
- Co-Autor*innen der Med Uni Graz
-
Rainer Peter
- Altmetrics:
- Abstract:
- Specific cardiomyopathies are structural or functional dis-eases of the heart muscle that are not explainable by coronary heart disease, valvular defects, arterial hypertension or congenital heart defects. They can be classified clinically based on the respective phe-notype into hypertrophic (HCM), dilated (DCM), re-strictive (RCM) and arrhythmogenic right ventricular cardiomyopathy (ARVC).Targeted, etiological diagnosis based on this clinical phenotype is decisive for adequate therapy. The detection of specific red flags plays a key role and is based on systematic taking of (family) history, ECG, echocardiography, magnetic resonance tomographhy, genetic testing and endomyocardial biopsy. In addition to general heart failure therapy, there are some cardiomyopathy-specific drug therapy options and indications for device therapy.
- Find related publications in this database (Keywords)
-
hypertrophic
-
restrictive
-
dilated
-
arrhythmogenic right ventricular
-
cardiomyopathy
-
genetic
-
family history